Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Tools & Techniques

AI tools against COVID-19: a view from where the rubber hits the road

A conversation on bias, speed and accuracy in AI approaches against COVID-19

June 23, 2020 9:11 PM UTC

Making machine learning an effective tool in the fight against COVID-19 requires broad access to data, scrupulous checks for bias, and strategies to balance speed and accuracy, according to researchers with AI-based diagnostics and literature-mining programs in a webinar co-sponsored by BioCentury and Life Sciences Washington.

Adaptive Biotechnologies Corp. (NASDAQ:ADPT) CEO and co-founder Chad Robins said the company’s work to rapidly characterize T cell responses to COVID-19 across thousands of patients “would not have been possible without machine learning.”...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article